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Dietary salt regulates expression of Tamm-Horsfall glycoprotein
in rats.
Background. Tamm-Horsfall glycoprotein (THP) is a unique
protein that is produced exclusively by cells of the thick ascending
limb of Henle’s loop (TALH). This study examined whether
dietary salt altered renal THP production.
Methods. Male Sprague-Dawley rats were examined on days 1,
4, and 15 following placement in metabolic cages on diet that
contained 0.3%, 1.0% or 8.0% NaCl. THP expression was quan-
tified using Northern hybridization and Western blotting analysis.
Results. An increase in dietary salt produced sustained increases
in relative steady-state mRNA and protein levels of THP in the
kidney. Addition of furosemide, but not chlorothiazide, to animals
on the 8.0% NaCl diet further augmented steady-state mRNA
levels of THP.
Conclusions. An increase in dietary salt and the loop diuretic,
furosemide, increased expression of THP in the rat. The data
support the involvement of this unique protein in the function of
the TALH during changes in dietary salt. These findings also
suggest that restriction of dietary salt may be beneficial in cast
nephropathy in multiple myeloma and recurrent nephrolithiasis,
two diseases in which THP can play an important pathogenetic
role.
Tamm-Horsfall glycoprotein (THP) was described ini-
tially as a urinary protein that inhibited viral hemaggluti-
nation [1]. Subsequently, Muchmore and Decker identified
a urinary protein that possessed immunosuppressive prop-
erties in vitro and hence coined the term uromodulin [2].
Interest in uromodulin resulted in cloning of this protein,
which was identified as THP [3, 4]; however, when further
studies did not suggest a major physiological function in
immune modulation, enthusiasm for the study of THP
diminished. The function of THP remained undefined, but
the exclusive production by cells of the thick ascending limb
of the loop of Henle (TALH) along with a striking absence
of THP mRNA in the macula densa [5], a specialized
portion of the TALH involved in the detection of the
luminal concentration of sodium chloride, suggested an
involvement in salt and water transport in the TALH.
However, the absence of aquaporins in the TALH [6–8]
has been proposed as the mechanism of water imperme-
ability of that segment. Along with studies showing that
water intake did not alter THP production [9], involvement
of THP in water transport in the TALH appeared unlikely.
Although not proven, THP may modulate salt transport in
the TALH.
We hypothesized that changes in dietary salt and the
addition of a loop diuretic altered the production of THP.
Understanding the involvement of these parameters in
THP expression is also potentially useful in the therapy of
diseases where THP plays an important role, such as cast
nephropathy (“myeloma kidney”) [10–15] and nephrolithi-
asis [16]. Using Northern hybridization and Western blot-
ting, the current study determined whether dietary salt
affected relative steady-state mRNA and renal protein
content of THP in Sprague-Dawley rats.
METHODS
Animal preparation
Seventy-six male Sprague-Dawley rats (Charles River
Laboratories, Wilmington, MA, USA), 28 days of age, were
housed under standard conditions and given 0.3% (low-
salt) diet (AIN-76A with 0.3% NaCl; Dyets, Inc., Bethle-
hem, PA, USA) and water ad libitum for four days before
initiating the experiment. Animals were used at this age
because previous experiments showed preservation of
blood pressure and inulin clearance for two weeks on an
8.0% NaCl diet [17]. Maintaining the animals on a 0.3%
NaCl diet allowed the establishment of a baseline standard-
ized diet before initiation of study. Rats were then placed in
metabolic cages and allowed free access to a water and rat
diet, which contained 0.3% (termed the Lo-salt group),
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1.0% (AIN-76A with 0.3% NaCl; Dyets, Inc.; the Mid-salt
group) or 8.0% (AIN-76A containing 8.0% NaCl, Dyets,
Inc.; the Hi-salt group) sodium chloride. Urine was col-
lected under oil to prevent desiccation. Food consumption,
urine flow and body weights were recorded daily. In other
experiments, rats on the high-salt diet received intraperito-
neal injections of either furosemide (Elkins-Sinn, Inc.,
Cherry Hill, NJ, USA), 5 mg/kg, (denoted Hi-F), or chlo-
rothiazide (Merck & Co., West Point, PA, USA), 4 mg/kg
(Hi-C), twice daily. Animals on the low-salt and high-salt
diets were killed on days 1, 4 and 15. Because of the
potential variable food and water intake, experiments were
not concluded before 24 hours. Both kidneys were imme-
diately harvested under aseptic conditions and either snap-
frozen in liquid nitrogen to isolate total RNA (see below)
or placed in a chilled solution that contained 250 mM
sucrose, 10 mM triethanolamine, 5 mg/ml leupeptin, 5 mg/ml
aprotinin and 0.1 mg/ml phenylmethylsulfonyl fluoride (pH
7.6; all from Sigma Chemical Co., St. Louis, MO, USA) in
order to obtain protein for Western blotting (see below).
Blood was collected for determination of serum sodium
concentration. Plasma and urine samples were analyzed for
sodium and potassium using flame photometry (model
IL-943; Instrumentation Laboratories, Inc., Lexington,
MA, USA).
Rat THP purification and description of monoclonal
anti-THP antibody
Rat THP was prepared by precipitation from urine using
0.64 M NaCl, according to the original protocol of Tamm
and Horsfall [1]. Purity of the isolated THP was established
by Coomassie blue staining following electrophoresis (SDS-
PAGE) using a 10% polyacrylamide gel. A mouse mono-
clonal anti-human THP antibody (#5B4E2) was raised in
our laboratory and purified from the medium using ammo-
nium sulfate precipitation, as described previously [10].
This monoclonal antibody reacted with deglycosylated hu-
man THP and thus was directed against a peptide portion
of the molecule. Immunoblotting was performed to deter-
mine whether this monoclonal antibody also recognized rat
THP. Following SDS-PAGE using 10% polyacrylamide gel
under reducing conditions, rat THP was transferred onto a
nitrocellulose membrane. After washing and blocking un-
bound sites on the nitrocellulose membrane in standard
fashion, the membrane was incubated with our mouse
anti-human THP monoclonal antibody, 50 mg/ml in phos-
phate-buffered saline containing 5% nonfat milk (Sigma
Chemical Co.), followed by goat anti-mouse IgG conju-
gated with horseradish peroxidase (Bio-Rad, Melville, NY,
USA), 1:2000 dilution in phosphate-buffered saline. After
additional washes, the membrane was developed using
ECL Western blotting system (Amersham International
plc., Buckinghamshire, UK) and XAR-5 film (Kodak,
Rochester, NY, USA). Under these conditions, a single
band at approximately 100 kD was identified, demonstrat-
ing immunoreactivity with rat THP (data not shown).
Western blot analysis
Protein was harvested from kidneys using the protocol of
Ecelbarger and associates; this protocol recovered mem-
brane-bound proteins and was used to examine THP
expression in that study [18]. Following placement of the
kidney in chilled membrane-isolation solution containing
250 mM sucrose, 10 mM triethanolamine, 5 mg/ml leupeptin,
5 mg/ml aprotinin and 0.1 mg/ml phenylmethylsulfonyl
fluoride (pH 7.6; all from Sigma Chemical Co.), the me-
dulla was dissected and then homogenized using a tissue
homogenizer (Omni-Mixer 17105; Omni Co., Waterbury,
CT, USA) in the same isolation solution. The homogenized
tissue was initially centrifuged at 1,000 3 g for 10 minutes,
and the supernatant was collected. To increase yield and to
effect more thorough homogenization, the pellet was again
homogenized and centrifuged at 1,000 3 g for 10 minutes.
Table 1. Compiled data of the groups of animals in the study
Group Day of study
Number of
animals Body wt g
UV˙ ml/day
UNa1V˙
mEq/min
UK1V˙
mEq/min
Serum [Na1]
mEq/liter per 100 g body weight
Lo-salt 1 8 110 6 6 143 6 4 7.4 6 0.6 0.13 6 0.02 0.2 6 0.04a
Nor-salt 1 4 128 6 4 ND 9.1 6 0.5 2.3 6 0.2 0.8 6 0.1
Hi-salt 1 8 115 6 4 145 6 6 38.0 6 2.2a 12.2 6 1.0a 0.8 6 0.1
Lo-salt 4 12 121 6 10 146 6 3 8.9 6 1.1b 0.2 6 0.03b 0.3 6 0.1a
Nor-salt 4 4 142 6 5 ND 11.2 6 0.7b 3.1 6 0.5b 1.1 6 0.2
Hi-salt 4 12 135 6 7 148 6 4 57.7 6 5.6 19.8 6 2.2 1.2 6 0.2
Hi-F 4 4 133 6 3 152 6 4 67.2 6 4.5 20.0 6 0.7 0.8 6 0.1
Hi-C 4 4 140 6 2 154 6 5 71.1 6 3.2 22.8 6 0.7 1.1 6 0.1
Lo-salt 15 7 190 6 13 137 6 4 15.6 6 3.0b 0.6 6 0.2b 1.0 6 0.2a
Nor-salt 15 4 223 6 11 ND 28.0 6 3.6b 8.3 6 1.2b 2.6 6 0.4
Hi-salt 15 8 178 6 7 136 6 5 87.0 6 9.3 48.3 6 10.6 2.2 6 0.3
ND is not done
a P , 0.05, compared to the other groups examined on that day
b P , 0.05, compared to the group on the 8.0% NaCl chow (Hi-salt) for the same duration
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This supernatant was combined with the previous collec-
tion. Crude membrane samples were prepared using a
single-speed fractionation procedure, which was character-
ized previously [7, 18]. In this protocol, the supernatant was
spun at 17,000 3 g for 20 minutes to obtain a pellet. The
pellets, which represented the crude plasma membrane
preparation, were resuspended in isolation solution and
protein concentration was determined using a kit (Micro
BCA Protein Assay Reagent Kit; Pierce, Rockford, IL,
USA). Samples containing 5 mg of total protein were
solubilized at 60°C for 15 minutes in Laemmli sample
buffer that contained b-mercaptoethanol, loaded into 8%
SDS-polyacrylamide minigels (Mini-PROTEAN II; Bio-
Rad Laboratory), and size-fractionated. The proteins were
electrophoretically transferred onto nitrocellulose mem-
brane. After blocking in 5% nonfat milk (Sigma Chemical
Co.), the membrane was probed with the mouse monoclo-
nal anti-THP antibody, 50 mg/ml in phosphate-buffered
saline containing 5% milk. Following addition of goat
anti-mouse IgG conjugated with horseradish peroxidase
(Bio-Rad Laboratory), 1:3000 dilution in phosphate-buff-
ered saline, the membrane was developed using peroxidase
substrate (0.8 mg/ml 3,39-diaminobenzidine in phosphate-
buffered saline; 0.01% hydrogen peroxide; all from Sigma
Chemical Co.). To quantify the amount of THP in each
sample, the density of each band was determined using a
densitometer (Model 620 Video Densitometer; Bio-Rad
Laboratory).
Northern hybridization analysis
Total RNA was isolated by single-step method of acid
guanidinium thiocyanate-phenol chloroform extraction
[19]. Briefly, kidneys were homogenized in a denaturing
solution of 4 M guanidinium isothiocyanate, 0.5% sarcosyl,
0.1 M b-mercaptoethanol in 25 mM sodium citrate (pH 7.0).
After phenol/chloroform extraction, the RNA was precip-
itated twice with isopropanol and washed with 70% etha-
nol. The concentration and purity of RNA in each sample
was determined using optical density at 260 and 280 nm.
Fifteen micrograms of total RNA from each sample was
electrophoresed in 1.0% agarose gels containing 2.2 M
formaldehyde and 0.2 M MOPS, pH 7.0. Before transfer,
each gel was stained with acridine orange to ensure the
quality of the RNA and to determine the location of the
18S and 28S ribosomal RNA. After the gel was rinsed in
distilled water, the gel was soaked in 50 mM NaOH for 10
minutes, then the samples were transferred to a nylon
membrane (Boehringer Mannheim Products, Mannheim,
Germany) using vacuum blotting (Model 785; Bio-Rad
Laboratory) in 103 SSC. Nucleic acids were cross-linked by
Fig. 1. Northern analysis using total RNA from kidneys of rats on an 8.0% or 0.3% NaCl diet. Samples were processed simultaneously and run on the
same gel. Animals were examined after one day (N 5 4 animals in each group) and after 15 days (N 5 4 in Hi-salt group and N 5 3 in Lo-salt group)
in metabolic cages while on these two diets. Steady-state levels of mRNA of THP were greater in the Hi-salt group compared to the corresponding
Lo-salt group examined at the same time point, by the first day of study, and remained elevated through day 15. The locations of 18S and 28S ribosomal
RNA in the gel were represented by the arrows.
Fig. 2. Summary of mean relative steady-states levels of mRNA of THP of
the Hi-salt (f), Lo-salt (M), Hi-F (u), and Hi-C (;) groups in this study.
Rats ingesting the 8.0% NaCl diet had sustained increases in steady-state
mRNA, compared to rats on 0.3% NaCl diet for the same duration.
Addition of furosemide, but not chlorothiazide, further increased steady-
state mRNA, compared to the other groups of animals in the study for
four days. *P , 0.05 than the corresponding Hi-salt group on that day of
study; ‡P , 0.05 than the other three groups on that day of study.
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short ultraviolet irradiation (Stratagene, La Jolla, CA,
USA). Membranes were prehybridized for 15 minutes at
68°C in a standard hybridization solution (QuikHyb; Strat-
agene). The membranes were hybridized at 68°C for 60
minutes with a 2.2 kb cDNA probe labeled with a-32P-
dCTP by random oligonucleotide priming (Prime-a-Gene
Labeling system; Promega, Inc., WI, USA). Rat THP
cDNA was kindly provided by Dr. George A. Scheele [20].
The blots were washed twice in 23 SSC in 0.1% SDS for 15
minutes at room temperature, followed by a single high-
stringency wash using 0.13 SSC in 0.1% SDS for 20 to 30
minutes at 60°C. Membranes were exposed to XAR-5 film
(Kodak), which was developed after overnight exposure at
280°C. The blots were then stripped in solution containing
1 mM Tris-HCI, pH 8.0, 0.1 mM EDTA and 0.13 Den-
hardt’s solution, at 75°C for two hours. The membranes
were then hybridized using a human glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) probe, which had
been labeled with 32P using the same method as that
described above. The human GAPDH probe (plasmid
pBR322) was obtained through American Type Culture
Collection (Rockville, MD, USA). Autoradiography was
then performed as described above. Autoradiographs were
scanned using a densitometer (Model 620 Video Densitom-
eter; Bio-Rad Laboratory). The density of the GAPDH
band in the same lane was used to normalize mRNA
loading. For quantification, the density of the THP bands
were individually divided by the density of band for
GAPDH in the same lane.
Statistical analysis
All data were expressed as mean 6 standard error.
Significant differences among data sets were determined
using either unpaired t-test or one-way analysis of variance
using multiple comparisons by Fisher’s protected least
significant difference method, where appropriate. A P
value of , 5% was considered significant.
RESULTS
Mean body wts, food intake, serum [Na1], urinary flow
rate (UV˙), and urinary sodium excretion (UNaV˙) and
potassium excretion (UKV˙) rates of the groups of rats in
this study were shown in Table 1. One animal in the Lo-salt
group died of unexplained causes. Mean body wts and
serum sodium concentrations did not differ among the
groups of rats studied on the same days. As expected,
compared to the Lo-salt and Mid-salt groups, rats on the
8.0% NaCl diet exhibited higher mean UV˙, UNaV˙, and
UKV˙ at each time of study (days 1, 4 and 15).
Mean relative steady-state mRNA levels of THP in-
creased (P , 0.05) by the first day and remained elevated
throughout the study, indicating a direct effect of dietary
salt on production of THP (Figs. 1 and 2). The effect of
furosemide was also examined. Four days following addi-
tion of furosemide to animals on the high-salt diet (Hi-F),
the mean amount of mRNA of THP was greater (P , 0.05)
than levels seen in animals on either the high-salt diet or
Fig. 3. Western blot of membrane preparations
obtained from the medulla of rats on the three
diets. All samples from the same day were
processed simultaneously and run on the same
gel. Animals were examined on days 1, 4 and 15.
A single band at approximately 100 kD was
identified by the mouse monoclonal anti-THP
antibody (#5B4E2).
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the low-salt diet. However, supplementation of rats on the
high-salt diet with chlorothiazide (Hi-C) produced no
further increases (Fig. 2).
Using Western blotting with a monoclonal antibody
(#5B4E2) that recognized rat THP (Methods section), an
increase in THP protein expression in the medulla was seen
after one day on 8.0% NaCl diet and persisted throughout
the study (Figs. 3 and 4). Differences in protein expression
between animals on 0.3% NaCl diet (Lo-salt) and those on
1.0% NaCl diet (Mid-salt) were also evident.
DISCUSSION
Production of THP occurs exclusively in the medullary
and cortical portions of the thick ascending limb of the loop
of Henle (TALH) [5, 21]. THP belongs to a unique class of
glycophospholipid-anchored proteins [22]. This post-trans-
lational modification directs THP to the apical surface of
cells of the TALH, but the protein remains embedded in
the outer leaflet of the lipid bilayer and extends into the
tubular lumen [22]. The unique physicochemical properties
and anatomic distribution suggest a role for THP in salt
transport activity in the TALH. Our current study demon-
strated that a high-salt diet increased steady-state levels of
mRNA, along with protein expression, of THP in the
kidney. The increase in mRNA occurred by the first day on
the high-salt diet and remained persistently elevated
through the 15-day course of the study. Finally, twice daily
administration of the loop diuretic, furosemide, but not
chlorothiazide, a diuretic that inhibits salt transport in the
early distal convoluted tubule, to rats on the high-salt diet
produced further increases in steady-state mRNA levels of
THP. Thus, although considered a constitutively produced
protein, our findings showed that this process was modified
under certain physiological conditions. While our present
study did not demonstrate the physiologic role of THP, an
increase in THP expression in the TALH, as seen in this
study, along with the increase in luminal [NaCl] that occurs
in rats during high-salt intake [23], directly promote self-
aggregation of THP [24–26]. Formation of a highly nega-
tively charged, hydrophobic, gelatinous barrier may de-
crease transepithelial electrolyte flux in the TALH.
The effect of changes in dietary salt on THP production
was not examined previously. Results of our experiments
that used furosemide agreed with several investigators [18,
27], but disagreed with others [9]. Using Western blotting,
Ecelbarger and associates clearly showed an increase in
THP in kidneys of rats exposed to furosemide [18]. Also,
Wirdnam and Milne demonstrated that furosemide stimu-
lated release of THP directly from cortical slices [27]. In
contrast to these studies and our current findings, however,
Bachmann et al showed that THP excretion did not change
one to three weeks following institution of furosemide, 12
mg/day, administered by osmotic minipumps [9]. Although
our study administered 5 mg/kg per day by intraperitoneal
injection, Ecelbarger and associates [18] administered 10
mg/day by osmotic minipumps over five days. Thus, differ-
ences in the doses of furosemide used in these studies does
not appear to explain the apparent discrepancy, which was
Fig. 4. Quantification of protein expression in the medulla of rats on the
various sodium chloride diets. The amount of THP was greatest (*P ,
0.05) in preparations obtained from animals on an 8.0% NaCl diet
(Hi-salt, N 5 4 rats), compared to rats on a 1.0% NaCl (Mid-salt, N 5 4)
and 0.3% NaCl (Lo-salt, N 5 4) at each of the time points studied. In
addition, the amount of THP in preparations from the Mid-salt groups
was greater (‡P , 0.05) than that obtained from the Lo-salt groups at each
time point examined.
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not determined. Certainly, THP expression in the kidney
may not correlate with protein excretion, which is techni-
cally difficult to assay in the urine [28]. In our present study,
the combined effect of furosemide and a high-salt diet was
greater than the effect of dietary salt alone.
In summary, the present study demonstrates that an
increase in dietary salt facilitated production of THP in
rats. The data also show that furosemide augments this
effect and provides additional confirmation of previous
studies [18, 27] that showed an effect of furosemide on
THP. Our findings suggest an involvement of THP in the
physiological function of the TALH. In addition, THP plays
an important role in pathological conditions that includes
cast nephropathy (“myeloma kidney”) and nephrolithiasis.
Cast nephropathy develops when nephrotoxic immuno-
globulin light chains bind to THP to produce a poorly
soluble complex that precipitates in the lumen of the distal
nephron and blocks flow of tubule fluid [10–15]. Intrarenal
expression of THP is particularly important in the patho-
genesis of this lesion. The role of THP in nephrolithiasis is
complex [16, 29, 30]. While THP from healthy volunteers
serves as an inhibitor of calcium oxalate formation, THP
from patients with recurrent stone formation augments
calcium oxalate aggregation [16]. In addition, a diet high in
sodium has been suggested to facilitate renal stone forma-
tion [31, 32]. By facilitating intrarenal expression of THP, a
high-salt diet, with or without furosemide, may produce
detrimental effects on renal function in patients with
multiple myeloma and facilitate renal stone formation in
predisposed individuals.
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APPENDIX
Abbreviations used in this paper are: GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; Hi-C, animals maintained on 8.0% NaCl chow
and given chlorothiazide; Hi-F, animals maintained on 8.0% NaCl chow
and given furosemide; Hi-salt, animals maintained on 8.0% NaCl chow;
Lo-salt, animals maintained on 0.3% NaCl chow; Mid-salt, animals
maintained on 1.0% NaCl chow; TALH, thick ascending limb of the loop
of Henle; THP, Tamm-Horsfall glycoprotein.
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